Table 2.
Baseline characteristics in gout cases and general population controls.
| Gout cases, n = 22,055 | Controls, n = 98,946 | p-value | |
|---|---|---|---|
| Age, years, mean (SD) | 67.1 (15.3) | 66.3 (15.4) | <0.0001 |
| Age, years, median (Q1, Q3) | 69 (57, 79) | 68 (56, 78) | <0.0001 |
| Male sex, n (%) | 14,926 (67.6) | 65,914 (66.5) | 0.002 |
| Annual income, EURO, median (Q1, Q3) | 15,600 (12,040, 23,450) | 16,230 (12,050, 24,760) |
<0.0001 |
| Education, n (%) | <0.0001 | ||
| ≤9 years | 8,716 (39.6) | 36,480 (36.9) | |
| 10–12 years | 8,938 (40.6) | 38,459 (39.0) | |
| ≥13 years | 4,013 (18.2) | 22,391 (22.7) | |
| Married, n (%) | 11,718 (53.3) | 52,694 (53.4) | 0.8 |
| Born outside Sweden, n (%) | 3,216 (14.6) | 13,611 (13.8) | 0.001 |
| Comorbidities, n (%) | |||
| Alcohol related disorders | 932 (4.2) | 2,337 (2.4) | <0.0001 |
| Hypertension | 12,590 (57.1) | 35,276 (35.7) | <0.0001 |
| Ischemic heart disease | 5,217 (23.7) | 13,265 (13.3) | <0.0001 |
| Heart failure | 4,180 (19.0) | 6,603 (6.7) | <0.0001 |
| Cerebrovascular disease | 2,269 (10.3) | 7,568 (7.7) | <0.0001 |
| Diabetes mellitus | 3,965 (18.0) | 10,550 (10.7) | <0.0001 |
| Dyslipidemia | 5,756 (26.1) | 15,859 (16.0) | <0.0001 |
| Obesity | 1,033 (4.7) | 1,642 (1.7) | <0.0001 |
| Chronic kidney disease | 964 (4.4) | 822 (0.8) | <0.0001 |
| Dementia | 545 (2.5) | 3,909 (4.0) | <0.0001 |
| Lung diseases | 3,181 (14.4) | 9,242 (9.3) | <0.0001 |
| Neoplasm | 2,608 (11.8) | 10,760 (10.9) | <0.0001 |
| Follow-up time years: | |||
| Mean (SD) | 5.5 (3.0) | 5.6 (3.0) | 0.02 |
| Median (Q1; Q3) | 5.2 (3.2; 7.7) | 5.3 (3.2; 7.7) | 0.04 |
SD, standard deviation; Q, quartile.